Germany / Italy / Latvia / Poland / United States / United Kingdom / /
Currency
USD / /
Event
FDA Phase / /
Facility
University Walk / Institute of Psychiatry / Institute of Pharmacology PAN / /
IndustryTerm
experimental protocol / treatment of the following disorders / buffered salt solution / iontophoretic applications / phencyclidine site / transmitter site / recognition site / extracellular solutions / polyamine modulatory site / stock solutions / intracellular solution / strychnine-insensitive modulatory site / food ad libitum / glycineB site / therapeutic applications / /
School of Medical Sciences / i.v. administration / Institute for Organic Synthesis / Institute of Psychiatry and Neurology / American Society for Pharmacology / HEADLEY Department of Pharmacology / Merz and Co. / Department of Physiology / Institute of Psychiatry / EPC / Division of the ED50 / s.c. administration / D-cycloserine administration / p.o. administration / /
Person
BORIS CHIZH / Spike / EDMUND PRZEGALINSKI / LEOKADIA BARAN / CHRISTINE WOLLENBURG / CHRIS G. PARSONS / WOJCIECH KOSTOWSKI / WOJCIECH DANYSZ / PAWEL KRZASCIK / SABINE HARTMANN / P. MAX / /
Position
G.P. / preclinical model for the possible utility / Representative / /